ZymeComms's profile picture. Specialist communications for life sciences

Zyme Communications

@ZymeComms

Specialist communications for life sciences

Fissato

🔬 Don't miss the latest Business of @MyBioTechniques! This month, we highlight #drugdiscovery #technology partnerships, product launches to support #cellandgenetherapy process development, & #investment in early #disease detection & #precisionmedicinerb.gy/59gvdf

ZymeComms's tweet image. 🔬 Don't miss the latest Business of @MyBioTechniques!

This month, we highlight #drugdiscovery #technology partnerships, product launches to support #cellandgenetherapy process development, & #investment in early #disease detection & #precisionmedicine ➡ rb.gy/59gvdf

Scottish Brain Sciences today announced that it has opened a new state-of-the-art clinical research centre at #ONEBioHub Aberdeen, a launchpad for start-ups and high potential life science companies looking to rapidly scale and grow. Read more here: bit.ly/4822S7B


.@MosaicTXLtd has appointed Dr Stephen Shuttleworth as CSO. With over 30 years of experience, Stephen will support the Company to bring its lead products into the clinic and to build out its pipeline of precision oncology programmes: shorturl.at/aNjay


Today @ShiftBioscience released new research detailing an improved framework for evaluating benchmark metric calibration in virtual cell models, reinforcing the use of AI virtual cells to accelerate target identification pipelines. Learn more: shiftbioscience.com/shift-bioscien…


TRIMTECH Therapeutics today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board. Read the full press release here: trimtechtherapeutics.com/trimtech-thera…


.@SPTLabtech and @AlitheaGenomics have collaborated to provide an automated solution for single-cell transcriptomics. The workflow integrates MERCURIUS FLASH-seq with SPT’s firefly platform, enabling high-throughput, cost efficient single-cell sequencing: sptlabtech.com/news/spt-labte…


Today @Optibrium introduced the latest release of its comprehensive molecular design platform, StarDrop 8, integrating collaboration at every stage of the discovery process enabling medicinal chemists to progress more quickly from hit to candidate. bit.ly/4nGfpn9


Today @nuclera announced expanded access to its eProtein Discovery System for APAC customers through a distributor agreement with Solve Scientific in Australia and New Zealand, providing localised support and expertise to scientists in these regions. bit.ly/3LsJYz3


.@proimmune has introduced ProVE SL Self-Loading Class I Monomers, designed to offer unprecedented flexibility, speed and MHC allele-coverage in T cell research, with over 50 alleles available. Read more: proimmune.com/news


.@valanxbio has appointed Klaus Orlinger, PhD as CSO. Klaus is an experienced R&D leader with a distinguished track record in pharmaceutical product development joining VALANX from HOOKIPA Pharma, where he served as CSO, VP Research, and Head of Virology: rb.gy/qva8kz


Today @qureight announced that its Vascul8™ model for pulmonary vascular disorders has been validated in a peer reviewed study, offering the potential to improve treatment options and patient outcomes following surgery. More: bit.ly/48OeEo5


OMED Health, part of Owlstone Medical, has partnered with @avivaplc to deliver a pilot study, providing 75 Aviva employees with OMED Health Plans. The collaboration will evaluate the impact of the OMED solution on the digestive health of participants: owlstonemedical.com/about/news/202…


Biodesix has expanded its partnership agreement with @BioRad to develop in vitro diagnostic assays for highly sensitive detection of genomic markers focused on oncology applications, utilizing Bio-Rad’s ddPCR™ technology & QX600 platform. More here: rb.gy/5wbz3q


.@proimmune has expanded into new global headquarters at Oasis Park, Oxford, supporting the continued development of ProImmune’s REVEAL Immunogenicity System and Ankyron target binding technologies. Read more: proimmune.com/news


.@gileschat has introduced giles, its specialised research agent designed to support healthcare, clinical, and medical research by optimising research intelligence for scientific text comprehension, enabling extraction and summarisation of academic papers: giles.app/press-release-…


.@BioRad today announced that MicroVal, the international certification organization, has approved the iQ-Check Enterobacteriaceae Kit for real time detection of Enterobacteriaceae in infant formula, infant cereal, and related ingredients: bio-rad.com/en-uk/life-sci…


Today @EnamineLtd announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of ASAP-0017445, a promising broad-spectrum coronavirus antiviral pre-clinical candidate. Read more: enamine.net/news-press-rel…


.@MosaicTXLtd has appointed Thomas Fuchs as CEO. With over 25 years of experience across drug development and commercialisation, Thomas will lead the Company to advance its pipeline of proprietary drug combination programmes into the clinic: mosaic-tx.com/wp-content/upl…


Cyclana Bio today announced the close of a £5M pre-seed funding round that will enable the Company to develop functional disease models and its platform for the identification of druggable targets in endometriosis. More here: cyclanabio.com/general-8


.@SPTLabtech and @10xGenomics have partnered to provide automated workflows for single cell research, allowing scientists to scale experiments on 10x’s Chromium Single Cell platform by providing plug-and-play protocols on SPT Labtech’s firefly platform: sptlabtech.com/news/spt-labte…


Today, @CN_Bio launched PhysioMimix Core, an all-in-one Organ-on-a-chip system, which combines the capabilities of CN Bio's existing suite of instruments, enabling single-, multi-organ and higher-throughput configurations within one scalable platform. bit.ly/3W6HxEv


Loading...

Something went wrong.


Something went wrong.